A Study of 2-Iminobiotin in Neonates With Perinatal Asphyxia

Status Terminated

Clinical Trial Summary

In case of insufficient oxygen supply to the brain of a newborn child (perinatal asphyxia), toxic compounds will be formed. These toxic compounds will damage the cells of the brain. 2 Iminobiotin (2 IB) is an investigational medicinal product that is related to vitamin B7. From studies in animals it has been shown that 2-IB may prevent the formation of the toxic compounds. Also it has been shown to be safe in in studies in juvenile animals and in healthy, adult male volunteers. The doctors hope that this will prevent (part of) the potential brain damage that may result from lack of oxygen to the brain.

This study is the first study in the target population: newborn with moderate to severe oxygen shortage during birth. In this study the investigators evaluate short term efficacy, safety and pharmacokinetics of 2-Iminobiotin. In the follow-up phase the investigators evaluate the long term efficacy and safety.

The study hypothesis is that 2-Iminobiotin will help to decrease the brain damage after oxygen shortage and is indeed safe. The brain damage will be measured both in the first week and during the first two years of life. The study was designed as a study with two parts an open label pilot part (6 patients) and a double-blind randomised part (60 patients). Due to lack of recruitment it was decided in September2014 to stop recruitment after the open label pilot part of the study (6 patients).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01626924
Study type	Interventional
Source	Neurophyxia B.V.
Contact
Status	Terminated
Phase	Phase 2
Start date	June 2012
Completion date	March 2016

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06322732` - Optimization of Routine Obstetric and Neonatal Care in the Management of Severe Perinatal Asphyxia in Term or Near-term Newborns: Analysis of Sub-optimal Care
Completed	`NCT05687708` - Effect of Non-nutritive Sucking on Transition to Oral Feeding in Infants With Asphyxia	N/A
Completed	`NCT00062452` - Esophageal Motility and Airway Defenses Among Infants	N/A
Completed	`NCT05946681` - Sildenafil Citrate to Improve Maternal and Neonatal Outcomes in Low-resource Settings
Completed	`NCT02002039` - Neuroprotective Role of Erythropoietin in Perinatal Asphyxia	Phase 2/Phase 3
Completed	`NCT04820504` - Augmented Infant Resuscitator to Enhance Newborn Ventilation	N/A
Completed	`NCT02071160` - Melatonin for Neuroprotection Following Perinatal Asphyxia	Phase 1/Phase 2
Recruiting	`NCT06090968` - Umbilical Cord Milking Versus Immediate Cord Clamping in Full Term Neonates (≥ 37 Weeks) Requiring Resuscitation	N/A
Completed	`NCT03854435` - Determination of Heart Rate in Infants Needing Resuscitation at Birth	N/A
Completed	`NCT02700854` - Hypoxic-Ischemic Encephalopathy Therapy Optimization in Neonates for Better Neuroprotection With Inhalative CO2	Phase 1
Active, not recruiting	`NCT05349175` - Augmented Infant Resuscitator (AIR): Transitioning a Novel Behavior Change Innovation to Drive Newborn Ventilation Skills Enhancement	N/A
Completed	`NCT03968861` - Outcome After 24 Months of Participants in the TOBY Xenon Study
Recruiting	`NCT05574855` - Evaluation of Haemodynamic in Neonates Treated With Hypothermia"
Completed	`NCT00624871` - Ascorbic Acid and Ibuprofen in Infants With Hypoxic Ischemic Encephalopathy	N/A